Gary Steven Long net worth and biography

Gary Long Biography and Net Worth

Insider of R1 RCM

Gary joined R1 in August, 2017 as Executive Vice President, Chief Commercial Officer. In this role, Gary will be responsible for R1’s customer growth initiatives, including sales, marketing, product management and solution development. Most recently, he was Senior Vice President and Chief Sales Officer at Premier Inc., where he developed and led the commercial organization.

Gary created a professional and sustainable market-focused organization while leading the business up to and beyond its successful IPO in 2013. Under Gary’s leadership the business more than doubled its annual revenues. Prior to Premier, Gary served as Senior Vice President of sales and support for Surgical Information Systems and previously worked at McKesson Corporation, where he held a series of progressive leadership roles in product management, corporate marketing and enterprise sales. Gary earned his bachelor's degree in Marketing from Auburn University and an MBA from Kennesaw State University. He resides in Atlanta, Georgia.

What is Gary Steven Long's net worth?: The estimated net worth of Gary Steven Long is at least $4.21 million as of April 8th, 2021. Mr. Long owns 293,867 shares of R1 RCM stock worth more than $4,205,237 as of December 21st. This net worth evaluation does not reflect any other investments that Mr. Long may own. Learn More about Gary Steven Long's net worth.
How do I contact Gary Steven Long?: The corporate mailing address for Mr. Long and other R1 RCM executives is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. R1 RCM can also be reached via phone at (312) 324-7820 and via email at [email protected]. Learn More on Gary Steven Long's contact information.
Has Gary Steven Long been buying or selling shares of R1 RCM?: Gary Steven Long has not been actively trading shares of R1 RCM over the course of the past ninety days. Most recently, Gary Steven Long sold 14,669 shares of the business's stock in a transaction on Thursday, April 8th. The shares were sold at an average price of $25.11, for a transaction totalling $368,338.59. Following the completion of the sale, the insider now directly owns 293,867 shares of the company's stock, valued at $7,379,000.37. Learn More on Gary Steven Long's trading history.
Who are R1 RCM's active insiders?: R1 RCM's insider roster includes Richard Evans, Jr. (Insider), Michael Feiner (Director), Joseph Flanagan (CEO), John Henneman, III (Director), Gary Long (Insider), Alex Mandl (Director), Lee Rivas (CEO), and John Sparby (COO). Learn More on R1 RCM's active insiders.
Are insiders buying or selling shares of R1 RCM?: In the last year, insiders at the healthcare provider sold shares 1 times. They sold a total of 10,046 shares worth more than $143,959.18. The most recent insider tranaction occured on March, 7th when President John M Sparby sold 10,046 shares worth more than $143,959.18. Insiders at R1 RCM own 36.8% of the company. Learn More about insider trades at R1 RCM.
Information on this page was last updated on 3/7/2024.

Gary Steven Long Insider Trading History at R1 RCM

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/8/2021	Sell	14,669	$25.11	$368,338.59	293,867
4/5/2021	Sell	5,837	$25.13	$146,683.81	214,436
4/1/2021	Sell	36,977	$25.04	$925,904.08	214,436

Gary Steven Long Buying and Selling Activity at R1 RCM

R1 RCM Company Overview

R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.

Today's Range

Now: $14.31

$14.30

$14.32

50 Day Range

MA: $14.28

$14.20

$14.31

2 Week Range

Now: $14.31

$8.87

$15.12

Volume

13,784,800 shs

Average Volume

3,577,960 shs

Market Capitalization

$6.04 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.